269 related articles for article (PubMed ID: 35891225)
21. Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China.
Tung TH; Lin XQ; Chen Y; Zhang MX; Zhu JS
Expert Rev Vaccines; 2022 Feb; 21(2):261-267. PubMed ID: 34894991
[TBL] [Abstract][Full Text] [Related]
22. Who gets COVID-19 booster vaccination? Trust in public health institutions and promotion strategies post-pandemic in the Republic of Korea.
Choi Y; Park S; Lee J; Kim Y; Kim BJ; Lin L; Fox AM
Vaccine; 2023 Dec; 41(50):7560-7572. PubMed ID: 37977939
[TBL] [Abstract][Full Text] [Related]
23. First COVID-19 Booster Dose in the General Population: A Systematic Review and Meta-Analysis of Willingness and Its Predictors.
Galanis P; Vraka I; Katsiroumpa A; Siskou O; Konstantakopoulou O; Katsoulas T; Mariolis-Sapsakos T; Kaitelidou D
Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891260
[TBL] [Abstract][Full Text] [Related]
24. Knowledge, Attitudes, and Practices of Adult Iraqi Population Towards COVID-19 Booster Dose: A Cross-Sectional Study.
Al-Qerem W; Jarab A; Hammad A; Alsajri AH; Al-Hishma SW; Ling J; Alabdullah AS; Salama A; Mosleh R
Patient Prefer Adherence; 2022; 16():1525-1537. PubMed ID: 35769339
[TBL] [Abstract][Full Text] [Related]
25. Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study.
Al-Qerem W; Al Bawab AQ; Hammad A; Ling J; Alasmari F
Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335042
[TBL] [Abstract][Full Text] [Related]
26. Effects of side-effect risk framing strategies on COVID-19 vaccine intentions: a randomized controlled trial.
Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
Elife; 2022 Aug; 11():. PubMed ID: 35971757
[TBL] [Abstract][Full Text] [Related]
27. The association between adverse events of COVID-19 vaccination and anxiety and willingness to receive a booster dose.
Chen L; Liang H; Liu L; Qiu W; Su L; Yang H
Hum Vaccin Immunother; 2023 Dec; 19(1):2176643. PubMed ID: 36798968
[TBL] [Abstract][Full Text] [Related]
28. A positive update on COVID-19 booster vaccine willingness among Danes.
Sønderskov KM; Vistisen HT; Dinesen PT; Østergaard SD
Dan Med J; 2022 Jan; 69(2):. PubMed ID: 35088699
[TBL] [Abstract][Full Text] [Related]
29. Determinants of the willingness of medical staff to vaccinate their children with a booster dose of the COVID-19 vaccine in Taizhou, China.
Huang LL; Tung TH; Jiang YH; Hu WW; Yang YP
Hum Vaccin Immunother; 2022 Nov; 18(6):2139098. PubMed ID: 36440977
[TBL] [Abstract][Full Text] [Related]
30. Willingness to receive the second booster of COVID-19 vaccine among older adults with cancer: a stratified analysis in four provinces of China.
Zhang L; Yang J; Su R; Lan X; Song M; Zhang L; Xu J
Front Public Health; 2024; 12():1298070. PubMed ID: 38454989
[TBL] [Abstract][Full Text] [Related]
31. Association between COVID-19 vaccine hesitancy and generalized trust, depression, generalized anxiety, and fear of COVID-19.
Sekizawa Y; Hashimoto S; Denda K; Ochi S; So M
BMC Public Health; 2022 Jan; 22(1):126. PubMed ID: 35042506
[TBL] [Abstract][Full Text] [Related]
32. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
[TBL] [Abstract][Full Text] [Related]
33. Key predictors of COVID-19 vaccine hesitancy in Malaysia: An integrated framework.
Ng JWJ; Vaithilingam S; Nair M; Hwang LA; Musa KI
PLoS One; 2022; 17(5):e0268926. PubMed ID: 35604921
[TBL] [Abstract][Full Text] [Related]
34. COVID-19 booster vaccine willingness.
Sønderskov KM; Vistisen HT; Dinesen PT; Østergaard SD
Dan Med J; 2021 Dec; 69(1):. PubMed ID: 34913428
[TBL] [Abstract][Full Text] [Related]
35. Acceptance of Annual Booster Doses of COVID-19 Vaccines Among Indian Healthcare Professionals: A Pan-India Cross-Sectional Survey.
Krishna E; Karthikeyan V; Ahmad S; Ranjan A; Hasan Km A; Pandey S; Kumar P; Singh CM
Cureus; 2023 Nov; 15(11):e49363. PubMed ID: 38146559
[TBL] [Abstract][Full Text] [Related]
36. COVID-19 Booster Vaccination Adverse Effects and Willingness to Receive a Yearly Booster Dose among Members of Health Sciences Faculties: A Descriptive Cross-Sectional Study.
Pandarathodiyil AK; Veerabhadrappa SK; Nabillah Ghani WM; Termizi Bin Zamzuri A
J Pharm Bioallied Sci; 2024 Apr; 16(Suppl 2):S1776-S1783. PubMed ID: 38882761
[TBL] [Abstract][Full Text] [Related]
37. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
[TBL] [Abstract][Full Text] [Related]
38. Association Between Risk Perception and Acceptance for a Booster Dose of COVID-19 Vaccine to Children Among Child Caregivers in China.
Qin C; Wang R; Tao L; Liu M; Liu J
Front Public Health; 2022; 10():834572. PubMed ID: 35372197
[TBL] [Abstract][Full Text] [Related]
39. The Association between Risk Perception and Hesitancy toward the Booster Dose of COVID-19 Vaccine among People Aged 60 Years and Older in China.
Qin C; Yan W; Tao L; Liu M; Liu J
Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891277
[TBL] [Abstract][Full Text] [Related]
40. Willingness to receive a COVID-19 booster vaccine and its associated factors among adults with chronic disease: A cross-sectional study in Putrajaya, Malaysia.
Abdullah NS; Ching SM; Ali H
Malays Fam Physician; 2023; 18():30. PubMed ID: 37292226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
